{"id":163586,"date":"2022-10-03T01:51:06","date_gmt":"2022-10-03T05:51:06","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/apellis-announces-24-month-phase-3-post-hoc-results-showing-treatment-with-pegcetacoplan-led-to-preservation-of-function-in-high-risk-areas-of-the\/"},"modified":"2024-08-18T11:45:22","modified_gmt":"2024-08-18T15:45:22","slug":"apellis-announces-24-month-phase-3-post-hoc-results-showing-treatment-with-pegcetacoplan-led-to-preservation-of-function-in-high-risk-areas-of-the","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/apellis-announces-24-month-phase-3-post-hoc-results-showing-treatment-with-pegcetacoplan-led-to-preservation-of-function-in-high-risk-areas-of-the.php","title":{"rendered":"Apellis Announces 24-Month Phase 3 Post Hoc Results Showing Treatment with Pegcetacoplan Led to Preservation of Function in High-Risk Areas of the&#8230;"},"content":{"rendered":"<p><![CDATA[WALTHAM, Mass., Sept.  30, 2022  (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced new data from the 24-month Phase 3 OAKS study of pegcetacoplan, an investigational targeted C3 therapy, for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration.]]><\/p>\n<p>Link:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/09\/30\/2526358\/0\/en\/Apellis-Announces-24-Month-Phase-3-Post-Hoc-Results-Showing-Treatment-with-Pegcetacoplan-Led-to-Preservation-of-Function-in-High-Risk-Areas-of-the-Retina-in-Patients-with-Geographi.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Apellis Announces 24-Month Phase 3 Post Hoc Results Showing Treatment with Pegcetacoplan Led to Preservation of Function in High-Risk Areas of the...\">Apellis Announces 24-Month Phase 3 Post Hoc Results Showing Treatment with Pegcetacoplan Led to Preservation of Function in High-Risk Areas of the...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Link: Apellis Announces 24-Month Phase 3 Post Hoc Results Showing Treatment with Pegcetacoplan Led to Preservation of Function in High-Risk Areas of the... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/apellis-announces-24-month-phase-3-post-hoc-results-showing-treatment-with-pegcetacoplan-led-to-preservation-of-function-in-high-risk-areas-of-the.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-163586","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163586"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=163586"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163586\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=163586"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=163586"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=163586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}